HM97662

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HM97662, covering 2025-04-30 to 2025-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors [Phase 1]